Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjogren's syndrome through Fas-mediated apoptosis

American Journal of Pathology

Volumn 155, Issue 1, 1999, Pages 173-181

  Ishimaru, Naozumi ^a   Saegusa, Kaoru ^a   Yanagi, Kumiko ^a   Haneji, Norio ^a   Saito, Ichiro ^a   Hayashi, Yoshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; ESTROGEN; ESTROGEN RECEPTOR; FAS ANTIGEN; FODRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; LYMPHOCYTE TRANSFORMATION; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SJOEGREN SYNDROME; T LYMPHOCYTE ACTIVATION;

EID: 0032983452     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65111-5     Document Type: Article

References (64)

1. Lahita RG: Sex steroids and the rheumatic diseases. Arthritis Rheum 1985, 28:121-126
2. Bateman A, Singh A, Kral T: The immune-hypothalamic-pituitary-adrenal axis. Endocrinol Rev 1989, 10:92-112
3. Grossman C: Possible underlying mechanisms of sexual dimorphism in the immune response: fact and hypothesis. J Steroid Biochem 1989, 34:241-251
4. Moorandian AD, Morley JE, Korennman SG: Biological actions of androgens. Endocrinol Rev 1987, 8:1-28
5. Lahita RG, Bradlow L, Fishman J, Kunkel HG: Estrogen metabolism in systemic lupus erythematosus: patients and family members. Arthritis Rheum 1982, 25:843-846
6. Zurier RB: Systemic Lupus Erythematosus. Edited by Lahita RG. New York, Wiley, 1987, pp 541-554
7. Inman RD: Immunologic sex differences and the female predominance in systemic lupus erythematosus. Arthritis Rheum 1978, 21: 849-852
8. Daniels T, Whitcher JP: Association of patients of labial salivary gland inflammation with keratoconjunctivitis sicca: analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994, 37:869-877
9. Makino S, Kuninato K, Muraoka Y, Katagiri K: The effect of castration on the appearance of diabetes in NOD mouse. Exp Animal 1981, 30:137-140
10. Siiteri PK, Jones LA, Roubinian J, Talal N: Sex steroids and the immune system. I. Sex differences in autoimmune disease in NZB/ NZW hybrid mice. J Steroid Biochem 1980, 12:425-432
11. Hawkins T, Gala RR, Dunbar JC: The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice. Proc Soc Exp Biol Med 1993, 202:201-205
12. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV: Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum 1986, 29:577-585
13. Kessler HS: A laboratory model for Sjögren's syndrome. Am J Pathol 1968, 52:671-685
14. Hoffman RW, Alspaugh MA, Waggie KS, Durham JB, Walker SE: Sjögren's syndrome in MRL/I and MRL/n mice. Arthritis Rheum 1984, 27:157-165
15. Jonnson R, Tarkowski RA, Backman K, Holmdahl R, Klareskog L: Sialadenitis in the MRL/I mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology 1987, 60:611-616
16. Haneji N, H. Hamano H, Yanagi K, Hayashi Y: A new animal model for primary Sjögren's syndrome in NFS/sld mutant mice. J Immunol 1994, 153:2769-2777
17. Stamenkvic I, Stegagno M, Wright KA, Krane SM, Amento EP. Colvin RB, Duquesnoy RJ, Kurnick JT: Clonal dominance among T lymphocyte infiltrates in arthritis. Proc Natl Acad Sci USA 1988, 85:1179-1183
18. Acha-Orbea H, Steinman L, McDevitt HO: T cell receptors in murine autoimmune diseases. Annu Rev Immunol 1989, 7:371-405
19. Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H. Hayashi Y: Identification of α-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997, 276:604-607
20. Ito M, Terasaki S, Itoh J, Katoh H, Yonehara S, Nose M: Rheumatic disease in an MRL strain of mice with a deficit in functional Fas ligand. Arthritis Rheum 1997, 40:1054-1063
21. Nishio A, Katakai T, Oshima C, Kasakura S, Sakai M, Yonehara S, Suda T, Nagata S, Masuda T: A possible involvement of Fas-Fas ligand signaling in the pathogenesis of murine autoimmune gastritis. Gastroenterology 1996, 111:956-967
22. Ludgate M, Jasani B: Apoptosis in autoimmune and non-autoimmune thyroid disease. J Pathol 1997, 182:123-124
23. Theofilopoulos A: Genetics of systemic autoimmunity. J Autoimmun 1996, 9:207-210
24. Nagata S, Golstein P: The Fas death factor. Science 1995, 267:1449-1456
25. Kong L, Ogawa N, Nakabayashi T, Lin G, Souza ED, McGuff H, Guerrero D, Talal N: Fas and Fas ligand expression in salivary glands of patients with primary Sjögren syndrome. Arthritis Rheum 1997, 40:87-97
26. Hayashi Y, Kojima A, Hata M, Hirokawa K: A new mutation involving the sublingual gland in NFS/N mice: Partially arrested mucous cell differentiation. Am J Pathol 1988, 132:187-191
27. Bain S, Jensen E, Celino D, Bailey M, Lantry M, Edwards M: High-dose gestagens modulate bone formation in the ovarieotomized mouse. J Bone Miner Res 1993, 8:219-224
28. Frazier-Jessen MR. Mott FJ, Witte PL, Kovacs EJ: Estrogen suppression of connective tissue deposition in a murine model of peritoneal adhesion formation. J Immunol 1996, 156:3036-3042
29. Gottardis MM, Ricchio ME, Satyyaswaroop PG, Jordon VC: Effect of steroidal and nonsteroidal antiestrogens on the growth of a tamoxifen-stimulated human endothelial carcinoma (EnCa101) in athymic nude mice. Cancer Res 1990, 50:3189-3192
30. White SC, Casarett GW: Induction of experimental autoallergic sialadenitis. J Immunol 1974, 112:178-185
31. Gold R, Schmied M, Giegerich G, Breitschopf H, Hartung HP, Tovka KV, Lassmann H: Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab Invest 1994, 71:219-225
32. + T cell clones into SCID mice. J Immunol Methods 1993, 158:27-36
33. Lea T, Vartdal F, Davies C, Ugelstad J: Magnetic monosized polymer particles for fast and specific fractionation of human mononuclear cells. Scand J Immunol 1985, 22:207-216
34. Hayashi Y, Haneji N, Hamano H, Yanagi K: Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Eur J Immunol 1994, 24:2826-2831
35. Yoshino K, S. Tseng S, Pflugfelder S: Substitute modulation of morphology, growth and tear protein production by cultured human lacrimal gland epithelial cells. Exp Cell Res 1995, 220:138-151
36. Hann L, Tatro J, Sullivan D: Morphology and function of lacrimal gland acinar cells in primary culture. Invest Ophthalmol Vis Sci 1989, 30: 145-158
37. Campbell PS, Ben-Aryeh H, Swanson KA: Differential distribution of an estrogen receptor in the submandibular and parotid salivary glands of female rats. Endocr Res 1990, 16:333-345
38. + human marrow cells is induced by IFN-γ and TNF-α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995, 85:3183-3190
39. Weller M, Frei K, Groscrurth P, Krammer PH, Yonekawa Y, Fontata A: Anti-Fas/Apo-1 antibody-mediated apoptosis of cultured human glioma cells: induction and modulation of sensitivity by cytokines. J Clin Invest 1994, 94:954-964
40. Theofilopoulos AN, Dixon DJ: Murine models of systemic lupus erythematosus. Adv Immunol 1985, 37:269-390
41. Steinberg AD, Melez KA, Raveche ES, Reeves JP, Boegel WA, Smathers PA, Taurog JD, Weinlein L, Duvic M: Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 1979, 22:1170-1176
42. Roubinian JR, Talal N, Greenspan JS, Goodman JR, Siteri PK: Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978, 147:1568-1583
43. Dalal M, S. Kim S, Voskuhl R: Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol 1997, 159:3-6
44. Mueller MN, Kappas A: Estrogen pharmacology. II. Suppression of experimental immune polyarthritis. Proc Exp Biol Med 1964, 117:845-847
45. Okayashu I, Kong YM, Rose NR: Effect of castration and sex hormones on experimental autoimmune thyroiditis. Clin Immunol Immunopathol 1981, 20:240-245
46. 0rnason BG, Richman DP: Effect of oral contraceptives on experimental demyelinating disease. Arch Neurol 1969, 21:103-107
47. Sato EH, Ariga H, Sallivan DA: Impact of androgen therapy in Sjögren's syndrome: Hormonal influence on lymphocyte populations and la expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci 1992, 33:2537-2545
48. Vendramini AC, Soo CH, Sullivan DA: Testosterone-induced suppression of autoimmune disease in lacrimal tissue of a mouse model (NZB/NZW F1) of Sjögren's syndrome. Invest Ophthalmol Vis Sci 1991, 32:3002-3006
49. Cohen JH, Danel L, Cordier G, Saez S, Revillard J-P: Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT-8-positive cells. J Immunol 1983, 131:2767-2771
50. Ahmed SA, Penhale WJ, Talal N: Sex hormone, immune responses and autoimmune diseases. Am J Pathol 1985, 121:531-551
51. Schurs AHWM, Verheul HAM: Effect of gender and sex steroids on the immune response. J Steroid Biochem 1990, 34:157-172
52. Medina KL, Smithson G, Kincade PW: Suppression of B lymphopoiesis during normal pregnancy. J Exp Med 1993, 178:1507-1515
53. Masuzawa T, Miura C, Onoe Y, Kusano K, Ohta H, Nozawa S, Suda T: Estrogen deficiency stimulates B lymphopoiesis in mouse bone marrow. J Clin Invest 1994, 94:1090-1097
54. Verthelyi D, Ahmed SA: 17β-Estradiol, but not 5α-dihydrotestosterone, augments antibodies to double-strand deoxyribonucleic acid in nonautoimmune C57BL/6J mice. Endocrinology 1994, 135:2615-2622
55. Duvic M, Steinberg A, Klassen L: Effect of the anti-estrogen, Nafoxidine, on NZB/W autoimmune disease. Arthritis Rheum 1978, 21:414-417
56. Brick J, Walker S, Wise K: Hormone control of autoantibodies to calf thymus nuclear extract (CTE) and DNA in MRL/lpr and MRL/+/+ mice. Clin Immunol Immunopathol 1988, 46:68-81
57. Cantatore FP, Loverro G, Ingrosso AM, Lacanna R, Sassanelli E, Selvaggi L, Carrozzo M: Effect of oestrogen replacement on bone metabolism and cytokines in surgical menopause. Clin Rheumatol 1995, 14:157-160
58. Ralston SH: Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Miner Res 1994, 9:883-890
59. Jilka RL, Hangoc G, Girasole G, Passeri G, Manolagas DC: Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992, 257:88-91
60. Fox HS, Bond BL, Parslow TG: Estrogen regulates the IFN-γ promoter. J Immunol 1991, 146:4362-4367
61. Giordano C, Stassi G, Maria RD, Todaro M, Richuiusa P, Papoff G, Ruberti G, Bagnasco M, Test R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997, 275:960-963
62. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA Jr, Matis LA: The role of Fas in autoimmune diabetes. Cell 1997, 89:17-24
63. Takabayashi H, Oida H, Fujisawa K, Yamaguchi M, Hikida T, Fukumoto M, Narumiya S, Kakizuka A: Hormone-induced apoptosis by Fas-nuclear receptor fusion protein: novel biological tools for controlling apoptosis in vivo. Cancer Res 1996, 56:4164-4170
64. Kameda T, Mono H, Yuasa T, Mori Y, Miyazawa K, Shiokawa M, Nakamura Y, Hiroi E, Hiura K, Kameda A, Yang N, Hakeda Y, Kumegawa M: Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclast. J Exp Med 1997, 186: 489-495